Burrell Terry-Ann
Director | Chief Financial Officer | CFO
2 companies
Insider Signal Score
81
ExcellentTrades Analyzed
13
12M Win Rate
84.6%
Avg 3M Return
+25.4%
Avg 12M Return
+39.9%
Burrell Terry-Ann is a Chief Financial Officer at Beam Therapeutics Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 30 sells.
Estimated insider holdings value: $3.2M based on current market prices.
Holdings by Company
Transaction History
Showing 10 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2024 | BEAM Beam Therapeutics Inc. | Chief Financial Officer | Sell | 5,446 | $32.12 | $174,925.52 | -7.2% | -29.4% | -46.0% | |
| Jul 13, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 117,000 | $12.07 | $1,412,413.53 | -22.6% | -45.2% | -32.8% | |
| Apr 4, 2023 | BEAM Beam Therapeutics Inc. | Chief Financial Officer | Sell | 4,640 | $29.74 | $137,978.26 | -4.6% | +8.0% | +0.4% | |
| Jan 27, 2023 | BEAM Beam Therapeutics Inc. | Chief Financial Officer | Sale+OE | 37,254 | $45.08 | $1,679,509.86 | -37.3% | -32.7% | -46.4% | |
| Jan 24, 2023 | BEAM Beam Therapeutics Inc. | Chief Financial Officer | Sale+OE | 20,236 | $45.02 | $910,947.25 | -24.4% | -31.5% | -44.4% | |
| Jan 18, 2023 | BEAM Beam Therapeutics Inc. | Chief Financial Officer | Sale+OE | 47,195 | $45.14 | $2,130,382.30 | -60.1% | -30.1% | -47.3% | |
| Mar 31, 2022 | BEAM Beam Therapeutics Inc. | CFO | Sell | 1,787 | $59.11 | $105,629.57 | -4.5% | -29.5% | -46.6% | |
| Jun 30, 2021 | BEAM Beam Therapeutics Inc. | CFO | Sale+OE | 30,000 | $122.00 | $3,660,000.00 | -31.7% | -29.2% | -69.9% | |
| Jun 28, 2021 | BEAM Beam Therapeutics Inc. | CFO | Sale+OE | 45,000 | $107.69 | $4,846,016.46 | -10.9% | -12.9% | -62.9% | |
| Jan 4, 2021 | BEAM Beam Therapeutics Inc. | CFO | Sale+OE | 25,000 | $81.78 | $2,044,484.79 | -15.2% | - | - |